We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

277 hedge funds and large institutions have $1.95B invested in Amneal Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

611% more call options, than puts

Call options by funds: $7.01M | Put options by funds: $985K

128% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 25

29% more capital invested

Capital invested by funds: $1.51B → $1.95B (+$437M)

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

12% more funds holding

Funds holding: 248 → 277 (+29)

1.15% more ownership

Funds ownership: 48.01% → 49.17% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
277
Holders Change
+29
Holders Change %
+11.69%
% of All Funds
3.37%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
57
Increased
100
Reduced
80
Closed
25
Calls
$7.01M
Puts
$985K
Net Calls
+$6.02M
Net Calls Change
-$921K

Top Buyers

1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$18.4M
2
Morgan Stanley
Morgan Stanley
New York
+$15M
3
PHS
PFM Health Sciences
California
+$12.7M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$12.5M
5
PCM
Penn Capital Management
Pennsylvania
+$11.5M

Top Sellers

1
NCM
Nantahala Capital Management
Connecticut
-$20.3M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$17.5M
3
Deutsche Bank
Deutsche Bank
Germany
-$9.56M
4
Prudential Financial
Prudential Financial
New Jersey
-$8.48M
5
Walleye Capital
Walleye Capital
New York
-$8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Rafferty Asset Management
176
Rafferty Asset Management
New York
$241K +$42.4K +3,705 +24%
Victory Capital Management
177
Victory Capital Management
Texas
$227K +$15.5K +1,351 +8%
Wealth Enhancement Advisory Services
178
Wealth Enhancement Advisory Services
Minnesota
$225K -$12.9K -1,127 -6%
EGM
179
Engineers Gate Manager
New York
$225K -$828K -72,399 -80%
SOADOR
180
State of Alaska Department of Revenue
Alaska
$221K +$6.2K +542 +3%
TI
181
Tidal Investments
Wisconsin
$221K +$200K +17,521 New
CFM
182
Catalyst Funds Management
Australia
$213K – – –
Renaissance Technologies
183
Renaissance Technologies
New York
$207K -$841K -73,500 -82%
AGM
184
Alpine Global Management
New York
$203K +$184K +16,083 New
HIP
185
HUB Investment Partners
Texas
$202K – – –
Mirae Asset Global Investments
186
Mirae Asset Global Investments
South Korea
$192K +$35.9K +3,134 +26%
Cerity Partners
187
Cerity Partners
New York
$182K +$26.5K +2,318 +19%
MFG
188
MidWestOne Financial Group
Iowa
$178K -$15.7K -1,370 -9%
PGFC
189
Peapack-Gladstone Financial Corp
New Jersey
$178K – – –
HW
190
Hamilton Wealth
California
$176K – – –
TRCT
191
Tower Research Capital (TRC)
New York
$176K +$106K +9,261 +197%
FCM
192
Fieldview Capital Management
Michigan
$163K +$148K +12,971 New
Canada Life
193
Canada Life
Manitoba, Canada
$159K – – –
AIP
194
Ameritas Investment Partners
Nebraska
$158K – – –
X
195
Xponance
Pennsylvania
$149K -$5.15K -450 -4%
VI
196
Vestcor Inc
New Brunswick, Canada
$133K -$147K -12,874 -55%
PCA
197
Pallas Capital Advisors
Massachusetts
$130K +$118K +10,355 New
MF
198
Magnetar Financial
Illinois
$129K +$117K +10,202 New
VT
199
Vise Technologies
New York
$128K +$116K +10,155 New
KAS
200
Kestra Advisory Services
Texas
$127K +$115K +10,045 New
6 7
8
9 10

AMRX Hedge Fund Activity: Q4 2025 in Review

277 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q4 2025, worth a combined $1.95B — up 29% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new AMRX positions and 25 closed out — a net gain of 32 holders — while 100 added to existing stakes and 80 trimmed.

The largest buyer was Assenagon Asset Management, adding an estimated $18.4M. The largest seller was Nantahala Capital Management, cutting an estimated $20.3M.

  • 277 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q4 2025, up from 248 in Q3 2025.
  • Funds reported $1.95B of Amneal Pharmaceuticals stock for Q4 2025, up 29% quarter-over-quarter.
  • 57 funds opened new Amneal Pharmaceuticals positions in Q4 2025 and 25 closed out, a net change of +32 holders.
  • The largest Amneal Pharmaceuticals buyer in Q4 2025 was Assenagon Asset Management, an estimated $18.4M added.
  • The largest Amneal Pharmaceuticals seller in Q4 2025 was Nantahala Capital Management, an estimated $20.3M sold.

Based on aggregated 13F filings for Q4 2025.